IPC
TEVA icon

Independent Portfolio Consultants’s Teva Pharmaceuticals TEVA Stock Holding History

Independent Portfolio Consultants’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$35K Sell
1,065
-260
-20% -$8.05K 0.01% 559
2017
Q1 		$43K Sell
1,325
-288
-18% -$9.83K 0.01% 584
2016
Q4 		$58K Sell
1,613
-52
-3% -$2.08K 0.02% 530
2016
Q3 		$77K Sell
1,665
-215
-11% -$11.2K 0.02% 482
2016
Q2 		$94K Sell
1,880
-100
-5% -$5.32K 0.03% 456
2016
Q1 		$106K Sell
1,980
-710
-26% -$41.7K 0.03% 463
2015
Q4 		$177K Sell
2,690
-10
-0.4% -$618 0.05% 349
2015
Q3 		$152K Sell
2,700
-65
-2% -$4.21K 0.03% 390
2015
Q2 		$163K Sell
2,765
-68
-2% -$4.2K 0.03% 403
2015
Q1 		$176K Sell
2,833
-197
-7% -$11.5K 0.04% 389
2014
Q4 		$174K Sell
3,030
-3,940
-57% -$220K 0.04% 399
2014
Q3 		$375K Sell
6,970
-325
-4% -$17.2K 0.1% 336
2014
Q2 		$382K Sell
7,295
-540
-7% -$27.6K 0.11% 330
2014
Q1 		$414K Sell
7,835
-2,190
-22% -$101K 0.13% 295
2013
Q4 		$402K Sell
10,025
-6,530
-39% -$257K 0.14% 306
2013
Q3 		$625K Sell
16,555
-8,455
-34% -$330K 0.25% 134
2013
Q2 		$980K Buy
+25,010
New +$974K 0.44% 38

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Independent Portfolio Consultants's TEVA Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Teva Pharmaceuticals (TEVA) stake by 20% in Q2 2017, selling an estimated $8.05K and leaving 1,065 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #559.

Independent Portfolio Consultants first reported a position in TEVA in Q2 2013 and has held it in 17 quarters since. The position peaked at $980K in Q2 2013. 649 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Independent Portfolio Consultants held 1,065 shares of Teva Pharmaceuticals worth $35K as of Q2 2017.
  • Independent Portfolio Consultants sold 260 Teva Pharmaceuticals shares in Q2 2017, an estimated $8.05K.
  • Teva Pharmaceuticals made up 0.01% of Independent Portfolio Consultants's portfolio in Q2 2017, its #559 holding.
  • Independent Portfolio Consultants first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • Independent Portfolio Consultants's Teva Pharmaceuticals position peaked at $980K in Q2 2013.
  • 649 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.